Accordingly, Nav1.5 knock-down [43] or the antiepileptic drug phenytoin [44] and the antianginal drug ranolazine [45], both Nav1.5 inhibitors, attenuate breast cancer metastasis in an orthotopic breast cancer and a tail vein cancer cell injection mouse model, respectively. The gene discussed is SCN5A; the disease is breast cancer.